Cargando…
Tolerability of a rapid‐escalation vinblastine‐prednisolone protocol in dogs with mast cell tumours
Optimal chemotherapy protocols for high‐risk mast cell tumours (MCTs) are unknown. The purpose of this study was to determine the tolerability and toxicity profile of a rapidly escalating vinblastine and prednisolone protocol (VPP) in which 3.00 mg/m(2) was administered once 7 days apart: at day 14...
Autores principales: | Serra Varela, Juan Carlos, Pecceu, Evi, Handel, Ian, Lawrence, Jessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645846/ https://www.ncbi.nlm.nih.gov/pubmed/29067202 http://dx.doi.org/10.1002/vms3.42 |
Ejemplares similares
-
Combination vinblastine, prednisolone and toceranib phosphate for treatment of grade II and III mast cell tumours in dogs
por: Olsen, Jaime A., et al.
Publicado: (2018) -
A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease.
por: McElwain, T. J., et al.
Publicado: (1977) -
Vasovagal tonus index (VVTI) as an indirect assessment of remission status in canine multicentric lymphoma undergoing multi-drug chemotherapy
por: Pecceu, Evi, et al.
Publicado: (2017) -
c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine
por: Weishaar, K.M., et al.
Publicado: (2017) -
Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone
por: Webster, Joshua D, et al.
Publicado: (2008)